ASVRX | PSOAX | ASVRX / PSOAX | |
Total Expense Ratio | 1.59 | 1.19 | 134% |
Annual Report Gross Expense Ratio | 1.59 | 1.28 | 124% |
Fund Existence | 15 years | 30 years | - |
Gain YTD | -16.568 | -15.743 | 105% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.18B | 1.05B | 399% |
Annual Yield % from dividends | 0.51 | 0.83 | 62% |
Returns for 1 year | -16.98 | -15.23 | 111% |
Returns for 3 years | -11.73 | -18.78 | 62% |
Returns for 5 years | 54.88 | 26.14 | 210% |
Returns for 10 years | -5.92 | -19.26 | 31% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WAEMX | 2.45 | 0.08 | +3.38% |
Wasatch Emerging Markets Small Cap Inv | |||
PXWIX | 30.46 | 0.64 | +2.15% |
Impax Ellevate Global Women's Ldr Instl | |||
MDOAX | 9.74 | 0.17 | +1.78% |
Morgan Stanley Developing Opportunity A | |||
ACSDX | 26.89 | 0.33 | +1.24% |
Invesco Comstock Y | |||
PEGEX | 17.75 | 0.20 | +1.14% |
PGIM Jennison Mid-Cap Growth R2 |